F-Star Biotechnologische Forschungs- und Entwicklungsges. m. b. H.

https://www.f-star.com

F-star is a clinical-stage biopharmaceutical company developing bispecific antibody immuno-oncology products selected for their potential to transform the treatment of cancer. Through the application of its highly efficient Modular Antibody Technology™ platform, F-star is the only biotechnology company able to create bispecific antibodies where the second binding site is in the constant Fc region of an antibody. The strength of the technology and programmes has been leveraged through partnerships with leading biopharmaceutical companies including AbbVie, Bristol-Myers Squibb, Merck Serono and Boehringer Ingelheim. F-star has currently one program in the clinic with a second immuno-oncology program heading toward IND. The Company has built a comprehensive IP estate around its technology and product pipeline, with over 50 patent applications filed and over 25 granted patents. F-star’s management team has a well-established track record in building successful biotech companies, and developing biologics. The team is advised by a world-leading scientific advisory board and a highly experienced board of directors. F-star has raised close to $100M in non-dilutive capital and revenues. The company currently employs over 60 people at its research site in Cambridge, UK. *

	Start	2006-01-01 established
	Industry	antibody technology
	Industry 2	therapeutic antibody
	Person	FitzGerald, Kevin (Activiomics 201304– CEO F-Star 201104–201205 CEO LEFT 5/12 + Isogenica + CAT)

	Region	Wien (Vienna)
	Country	Austria
	Street	7 Schwarzenbergplatz
	City	1030 Wien
	Tel	+43-72055-4215
		Address record changed: 2020-12-02

Basic data	Employees	B: 11 to 50 (2013-10-17)

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for Sino Biopharm (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)